Aggrephagy Deficiency in the Placenta: A New Pathogenesis of Preeclampsia
Aggrephagy is defined as the selective degradation of aggregated proteins by autophagosomes. Protein aggregation in organs and cells has been highlighted as a cause of multiple diseases, including neurodegenerative diseases, cardiac failure, and renal failure. Aggregates could pose a hazard for cell survival. Cells exhibit three main mechanisms against the accumulation of aggregates: protein refolding by upregulation of chaperones, reduction of protein overload by translational inhibition, and protein degradation by the ubiquitin–proteasome and autophagy–lysosome systems. Deletion of autophagy-related genes reportedly contributes to intracellular protein aggregation in vivo. Some proteins recognized in aggregates in preeclamptic placentas include those involved in neurodegenerative diseases. As aggregates are derived both intracellularly and extracellularly, special endocytosis for extracellular aggregates also employs the autophagy machinery. In this review, we discuss how the deficiency of aggrephagy and/or macroautophagy leads to poor placentation, resulting in preeclampsia or fetal growth restriction..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
International Journal of Molecular Sciences - 22(2021), 5, p 2432 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Akitoshi Nakashima [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Aggrephagy |
|---|
| doi: |
10.3390/ijms22052432 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ052686612 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ052686612 | ||
| 003 | DE-627 | ||
| 005 | 20240414083953.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/ijms22052432 |2 doi | |
| 035 | |a (DE-627)DOAJ052686612 | ||
| 035 | |a (DE-599)DOAJdfb33799a018408eb80c96376573eef6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a QH301-705.5 | |
| 050 | 0 | |a QD1-999 | |
| 100 | 0 | |a Akitoshi Nakashima |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Aggrephagy Deficiency in the Placenta: A New Pathogenesis of Preeclampsia |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Aggrephagy is defined as the selective degradation of aggregated proteins by autophagosomes. Protein aggregation in organs and cells has been highlighted as a cause of multiple diseases, including neurodegenerative diseases, cardiac failure, and renal failure. Aggregates could pose a hazard for cell survival. Cells exhibit three main mechanisms against the accumulation of aggregates: protein refolding by upregulation of chaperones, reduction of protein overload by translational inhibition, and protein degradation by the ubiquitin–proteasome and autophagy–lysosome systems. Deletion of autophagy-related genes reportedly contributes to intracellular protein aggregation in vivo. Some proteins recognized in aggregates in preeclamptic placentas include those involved in neurodegenerative diseases. As aggregates are derived both intracellularly and extracellularly, special endocytosis for extracellular aggregates also employs the autophagy machinery. In this review, we discuss how the deficiency of aggrephagy and/or macroautophagy leads to poor placentation, resulting in preeclampsia or fetal growth restriction. | ||
| 650 | 4 | |a aggrephagy | |
| 650 | 4 | |a aggresome | |
| 650 | 4 | |a autophagy | |
| 650 | 4 | |a endoplasmic reticulum stress | |
| 650 | 4 | |a inflammation | |
| 650 | 4 | |a placenta | |
| 653 | 0 | |a Biology (General) | |
| 653 | 0 | |a Chemistry | |
| 700 | 0 | |a Tomoko Shima |e verfasserin |4 aut | |
| 700 | 0 | |a Sayaka Tsuda |e verfasserin |4 aut | |
| 700 | 0 | |a Aiko Aoki |e verfasserin |4 aut | |
| 700 | 0 | |a Mihoko Kawaguchi |e verfasserin |4 aut | |
| 700 | 0 | |a Atsushi Furuta |e verfasserin |4 aut | |
| 700 | 0 | |a Ippei Yasuda |e verfasserin |4 aut | |
| 700 | 0 | |a Satoshi Yoneda |e verfasserin |4 aut | |
| 700 | 0 | |a Akemi Yamaki-Ushijima |e verfasserin |4 aut | |
| 700 | 0 | |a Shi-Bin Cheng |e verfasserin |4 aut | |
| 700 | 0 | |a Surendra Sharma |e verfasserin |4 aut | |
| 700 | 0 | |a Shigeru Saito |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t International Journal of Molecular Sciences |d MDPI AG, 2003 |g 22(2021), 5, p 2432 |w (DE-627)DOAJ00014584X |x 14220067 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2021 |g number:5, p 2432 |
| 856 | 4 | 0 | |u https://doi.org/10.3390/ijms22052432 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/dfb33799a018408eb80c96376573eef6 |z kostenfrei |
| 856 | 4 | 0 | |u https://www.mdpi.com/1422-0067/22/5/2432 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1661-6596 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1422-0067 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2021 |e 5, p 2432 | ||